Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.10.0.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2018
Dec. 31, 2017
Current assets    
Cash and cash equivalents $ 98,591 $ 113,915
Accounts receivable 5,321 7,758
Short-term investments (certificates of deposit) 35,000 36,002
Cash deposits with clearing organizations 836 1,041
Receivables from broker-dealers and clearing organizations 11,412 7,395
Forgivable loans receivable 1,598 1,616
Securities owned, at fair value 3,812 1,985
Inventory 299 171
Other receivables - related party 775 618
Prepaid expenses and other current assets 13,880 12,680
Total current assets 171,524 183,181
Property and equipment, net 14,163 9,513
Restricted cash 17,389 17,387
Long-term investments, at fair value 565 1,390
Intangible assets 13,614 15,223
Goodwill 18,645 18,645
Other assets 966 611
Total assets 236,866 245,950
Current liabilities    
Accounts payable and accrued expenses 38,126 36,127
Accounts payable and accrued expenses - related party 73 222
Accrued commissions and payroll payable 10,652 10,065
Deferred clearing and marketing credits 681 786
Securities sold, not yet purchased, at fair value 8 151
Warrants issued - National 0 5,597
Interest payable 1,143 887
Interest payable - related party 94 97
Notes payable, short-term (net of debt discount of $0 and $973 at June 30, 2018 and December 31, 2017, respectively) 0 8,528
Subsidiary convertible note, short-term, at fair value 10,573 4,700
Deferred revenue 650 0
Derivative warrant liability 0 87
Other current liabilities 158 181
Total current liabilities 62,158 67,428
Notes payable, long-term (net of debt discount of $1,035 and $62 at June 30, 2018 and December 31, 2017, respectively) 73,456 43,222
Subsidiary convertible note, long-term, at fair value 0 10,059
Other long-term liabilities 4,987 4,739
Total liabilities 140,601 125,448
Stockholders' equity    
Preferred stock, $0.001 par value, 15,000,000 authorized, 5,000,000 designated Series A shares, 1,000,000 shares issued and outstanding as of June 30, 2018 and December 31, 2017, respectively; liquidation value of $25.00 per share 1 1
Common stock, $0.001 par value, 100,000,000 shares authorized, 53,987,074 and 50,991,285 shares issued and outstanding as of June 30, 2018 and December 31, 2017, respectively 54 51
Common stock issuable, 259,813 and 158,015 shares as of June 30, 2018 and December 31, 2017, respectively 776 500
Additional paid-in-capital 397,858 364,148
Accumulated deficit (354,756) (312,127)
Total stockholders' equity attributed to the Company 43,933 52,573
Non-controlling interests 52,332 67,929
Total stockholders' equity 96,265 120,502
Total liabilities and stockholders' equity $ 236,866 $ 245,950